|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Zhang S, Zeng H, Fan Y,
Qiao Y and Zhou Q: Esophageal cancer incidence and mortality in
China, 2010. Thorac Cancer. 5:343–348. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pennathur A, Gibson MK, Jobe BA and
Luketich JD: Oesophageal carcinoma. Lancet. 381:400–412. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shen J, Stass SA and Jiang F: MicroRNAs as
potential biomarkers in human solid tumors. Cancer Lett.
329:125–136. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sorel O and Dewals BG: MicroRNAs in large
herpesvirus DNA genomes: Recent advances. Biomol Concepts.
7:229–239. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mitchell PS, Parkin RK, Kroh EM, Fritz BR,
Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant
KC, Allen A, et al: Circulating microRNAs as stable blood-based
markers for cancer detection. Proc Natl Acad Sci USA.
105:10513–10518. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Paulmurugan R: MicroRNAs-a new generation
molecular targets for treating cellular diseases. Theranostics.
3:927–929. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rashed MH, Kanlikilicer P,
Rodriguez-Aguayo C, Pichler M, Bayraktar R, Bayraktar E, Ivan C,
Filant J, Silva A, Aslan B, et al: Exosomal miR-940 maintains
SRC-mediated oncogenic activity in cancer cells: A possible role
for exosomal disposal of tumor suppressor miRNAs. Oncotarget.
8:20145–20164. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang F, Wang Z, Gu X and Cui J: miR-940
upregulation suppresses cell proliferation and induces apoptosis by
targeting PKC-δ in ovarian cancer OVCAR3 cells. Oncol Res.
25:107–114. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rice TW, Ishwaran H, Ferguson MK,
Blackstone EH and Goldstraw P: Cancer of the esophagus and
esophagogastric junction: An eighth edition staging primer. J
Thorac Oncol. 12:36–42. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Livak KJ and Schimittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ohashi S, Miyamoto S, Kikuchi O, Goto T,
Amanuma Y and Muto M: Recent advances from basic and clinical
studies of esophageal squamous cell carcinoma. Gastroenterology.
149:1700–1715. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pereira DM, Rodrigues PM, Borralho PM and
Rodrigues CM: Delivering the promise of miRNA cancer therapeutics.
Drug Discov Today. 18:282–289. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Harada K, Baba Y, Ishimoto T, Shigaki H,
Kosumi K, Yoshida N, Watanabe M and Baba H: The role of microRNA in
esophageal squamous cell carcinoma. J Gastroenterol. 51:520–530.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Feber A, Xi L, Luketich JD, Pennathur A,
Landreneau RJ, Wu M, Swanson SJ, Godfrey TE and Litle VR: MicroRNA
expression profiles of esophageal cancer. J Thorac Cardiovasc Surg.
135:255–260. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liang D, Xu X, Deng F, Feng J, Zhang H,
Liu Y, Zhang Y, Pan L, Liu Y, Zhang D, et al: miRNA-940 reduction
contributes to human Tetralogy of Fallot development. J Cell Mol
Med. 18:1830–1839. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xu T, Zhou Q, Che L, Das S, Wang L, Jiang
J, Li G, Xu J, Yao J, Wang H, et al: Circulating miR-21, miR-378,
and miR-940 increase in response to an acute exhaustive exercise in
chronic heart failure patients. Oncotarget. 7:12414–12425.
2016.PubMed/NCBI
|
|
18
|
Rajendiran S, Parwani AV, Hare RJ,
Dasgupta S, Roby RK and Vishwanatha JK: MicroRNA-940 suppresses
prostate cancer migration and invasion by regulating MIEN1. Mol
Cancer. 13:2502014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ma J, Sun F, Li C, Zhang Y, Xiao W, Li Z,
Pan Q, Zeng H, Xiao G, Yao K, et al: Depletion of intermediate
filament protein nestin, a target of microRNA-940, suppresses
tumorigenesis by inducing spontaneous DNA damage accumulation in
human nasopharyngeal carcinoma. Cell Death Dis. 5:e13772014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ding D, Zhang Y, Yang R, Wang X, Ji G, Huo
L, Shao Z and Li X: miR-940 Suppresses tumor cell invasion and
migration via regulation of CXCR2 in hepatocellular carcinoma.
Biomed Res Int. 2016:76183422016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu X, Ge X, Zhang Z, Zhang X, Chang J, Wu
Z, Tang W, Gan L, Sun M and Li J: MicroRNA-940 promotes tumor cell
invasion and metastasis by downregulating ZNF24 in gastric cancer.
Oncotarget. 6:25418–25428. 2015.PubMed/NCBI
|
|
22
|
Wang R, Wu Y, Huang W and Chen W:
MicroRNA-940 targets INPP4A or GSK3β and activates the
Wnt/β-catenin pathway to regulate the malignant behavior of bladder
cancer cells. Oncol Res. 26:145–155. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang HW, Liu GH, Liu YQ, Zhao HC, Yang Z,
Zhao CL, Zhang XF and Ye H: Over-expression of microRNA-940
promotes cell proliferation by targeting GSK3β and sFRP1 in human
pancreatic carcinoma. Biomed Pharmacother. 83:593–601. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yuan B, Liang Y, Wang D and Luo F: MiR-940
inhibits hepatocellular carcinoma growth and correlates with
prognosis of hepatocellular carcinoma patients. Cancer Sci.
106:819–824. 2015. View Article : Google Scholar : PubMed/NCBI
|
